To further promote and protect public health, it is important that people who participate in clinical trials represent those populations most likely to benefit from the potential medical product, technology or device. In that spirit, the U.S Food and Drug Administration issued final guidance with the agency’s recommendations on designing and executing clinical trials of drugs and biologics that include people with different demographic characteristics (e.g., sex, race, ethnicity, age, location of residency) and non-demographic characteristics (e.g., patients with organ dysfunction, comorbid conditions, and disabilities; those at weight range extremes; and populations with diseases or conditions with low prevalence). READ MORE>>
We want to be your business partner of choice when seeking sites for your clinical trials. For more than 20 years, we have worked in medical research in the pharmaceutical and medical devices industries. We have experience in several therapeutic areas, in both US domestic and International markets, with professional relationships with leaders and healthcare professionals in diverse settings and systems. Some of us have also worked with various Sponsors and CROs, clinical sites, academic centers, hospital systems and research networks.
